Previous 10 | Next 10 |
Merit Medical Systems (MMSI): Q1 Non-GAAP EPS of $0.52 beats by $0.16; GAAP EPS of $0.19 beats by $0.07.Revenue of $248.9M (+2.2% Y/Y) beats by $17.93M.Press Release For further details see: Merit Medical Systems EPS beats by $0.16, beats on revenue
Q1 2021 reported revenue of $248.9 million, up 2.2% compared to Q1 2020 Q1 2021 constant currency revenue, organic* up 0.6% compared to Q1 2020 Q1 2021 GAAP EPS of $0.19, compared to GAAP loss per share of ($0.06) in Q1 2020 Q1 2021 non-GAAP EPS* of $0.52, compared to $0.38 in...
San Diego, California--(Newsfile Corp. - April 27, 2021) - The Shareholders Foundation, Inc. announces that an update in the lawsuit that is pending for certain investors in NYSE: MMSI shares. Investors, who purchased shares of Merit Medical Systems, Inc. (NYSE: MMSI) in February 2019 or earl...
SAN DIEGO, April 20, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Merit Medical Systems, Inc. (NYSE: MMSI) shares. Investors, who purchased shares of Merit Medical Systems, Inc. (NYSE: MMSI) in February 2019 or e...
SOUTH JORDAN, Utah, April 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical c...
SOUTH JORDAN, Utah, April 08, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, cr...
Merit Medical is trading within sight of an all-time high as the company looks to procedure volume recovery, new product launches, and a significant margin improvement initiative. Sample collection kit sales for COVID-19 testing were an invaluable offset to procedure volume declines i...
Merit Medical Systems ([[MMSI]] +0.8%) announces the enrollment of the first patients in its Wrapsody ArterioVenous ((AV)) Access Efficacy Pivotal Study of the WRAPSODY Endovascular Stent Graft, an investigational device being studied for the treatment of stenosis or occlusion within dialysis...
SOUTH JORDAN, Utah, March 11, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, cr...
Image source: The Motley Fool. Merit Medical Systems Inc (NASDAQ: MMSI) Q4 2020 Earnings Call Feb 24, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Merit Medical Systems Inc (MMSI) Q4 2020 Earnings Call Transcript...
News, Short Squeeze, Breakout and More Instantly...
Merit Medical Systems Inc. Company Name:
MMSI Stock Symbol:
NASDAQ Market:
Merit Medical Systems Inc. Website:
Asset acquisition expands Merit’s endoscopy portfolio with a minimally invasive solution for patients suffering from chronic gastroesophageal reflux disease (GERD). Asset acquisition projected to add approximately $30 million of revenue, on an annualized basis, in key gastroint...
2024-06-23 06:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SOUTH JORDAN, Utah, June 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2024, after the close of the stock marke...